ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Anti-Angiotensin II Type 1-Receptor Antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA Antibody-Mediated Rejection

    C. Lefaucheur,1 D. Viglietti,1 O. Aubert,1 A. Philippe,2 P. Halloran,3 A. Loupy,1 D. Dragun.2

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2Medical Faculty of the Charité, Berlin, Germany; 3Alberta Transplant Applied Genomics Centre, Edmonton, Canada.

    AT1R-Ab have been associated with kidney allograft rejection; however, their ability to induce a specific rejection phenotype, independent of HLA-DSAs, has not been defined.In a…
  • 2018 American Transplant Congress

    Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies

    F. Shihab,1 Y. Qazi,1,2 V. Peddi,1 D. Shaffer,1 D. Kim,1,2 K. McCague,3 D. Patel,3 S. Mulgaonkar.1,2

    1US92 Study Group, Salt Lake City; 2TRANSFORM Study Group, East Hanover; 3Novartis Pharmaceuticals Corporation, East Hanover.

    Purpose: Attainment of everolimus (EVR) target trough level (C0 3-8ng/mL) is crucial in achieving comparable efficacy-safety with EVR+reduced (r) calcineurin inhibitor regimen (CNI; tacrolimus [TAC]…
  • 2018 American Transplant Congress

    Kidney Transplant Rejection is Associated with Robust and Prolonged Bioenergetic Reprogramming and Metabolic Maladaptation

    A. Zmijewska, J. Zmijewski, J. Chen, R. Mannon.

    Medicine, University of Alabama at Birmingham, Birmingham, AL.

    Introduction: Metabolic plasticity and mitochondrial bioenergetic homeostasis are altered due to a organ ischemia. However, the impact of the alloimmune response on the allograft is…
  • 2018 American Transplant Congress

    Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial

    C. Leibler,1 F. Canoui,2 M. Matignon,1 E. Rondeau,3 A. Zarour,2 A. Durrbach,4 S. Malard,5 P. Grimbert.1

    1Nephrology Transplantation, APHP Henri Mondor, Creteil, France; 2Public Health, APHP Henri Mondor, Creteil, France; 3Nephrology Transplantation, APHP Tenon, Paris, France; 4Nephrology Transplantation, APHP Bicêtre, Le Kremlin Bicêtre, France; 5Histocompatibility, APHP Saint Louis, Paris, France.

    IntroductionAntibody-mediated rejection (ABMR) is currently a critical question in kidney transplant recipient with immunological risk factors such as pre transplant donor-specific anti HLA antibodies (DSA).…
  • 2018 American Transplant Congress

    Use of Proton-Pump Inhibitors is Associated with Lower Magnesium and Iron Status and Excess Mortality in Renal Transplant Recipients

    A. Gomes-Neto,1 R. Douwes,1 M. Eisenga,1 S. Berger,1 R. Gans,1 E. Berg,1 G. Navis,1 H. Blokzijl,2 S. Bakker.1

    1Nephrology, UMCG, Groningen, Netherlands; 2Gastroenterology and Hepatology, UMCG, Groningen, Netherlands.

    BackgroundProton-pump inhibitor (PPI) use is common in renal transplant recipients (RTR). However, PPI use may induce micronutrient deficiencies and has been associated with increased mortality…
  • 2018 American Transplant Congress

    The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

    A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.

    Northwestern Memorial Hospital, Chicago, IL.

    Rituximab is an antibody that binds to the CD20 antigen on B cells resulting in rapid and prolonged depletion. At Northwestern Memorial Hospital, a single…
  • 2018 American Transplant Congress

    Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function

    S. Bernd,2 P. Heeger,1 T-.P. Heather,3 I. Hall,7 M. Doshi,4 F. Weng,5 P. Reese,6 C. Parikh.3

    1Icahn School of Medicine Mount Sinai, New York, NY; 2University of Ulm, Ulm, Germany; 3Yale University School of Medicine, New Haven, CT; 4Wayne State University, Detroit, MI; 5Barnabas Health, Livingston, NJ; 6University of Pennsylvania, Philadelphia, PA; 7University of Utah School of Medicine, Salt Lake City, UT.

    Purpose: Delayed graft function (DGF) is associated with increased allogaft immunogenicity and decreased long-term survival. We hypothesized that high levels of donor urinary biomarkers for…
  • 2018 American Transplant Congress

    Inflammation in Fibrotic Areas (i-IF/TA) Identifies a T Cell-Mediated Rejection Component of IF/TA with Poor Kidney Allograft Outcome

    D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.

    Paris Translational Research Center for Organ Transplantation, Paris, France.

    Addressing the etiological heterogeneity of interstitial fibrosis in kidney allografts represents an important challenge to improve long-term transplant outcomes. We investigated the determinants, clinical and…
  • 2018 American Transplant Congress

    A Novel Nomogram-Based Approach for Defining the Effect of Transplantation on Cancer Recurrence Risk

    N. Ejaz,1 R. Alloway,1 F. Paterno,1 A. Singhal,1 X. Ji,2 M. Kattan,2 E. Woodle.1

    1U of Cincinnati, Cincinnati; 2Cleveland Clinic, Cleveland.

    The effect of transplantation on renal cell cancer (RCC) recurrence risk has not yet been precisely defined. Validated nomograms for predicting RCC recurrence risk (viz,…
  • 2018 American Transplant Congress

    Effects of IdeS on HLA-SAB, C1q-SAB and CDC-XM

    S. Järnum,1 A. Runström,1 L. Winstedt,1 T. Lorant,2 C. Kjellman.1

    1Hansa Medical AB, Lund, Sweden; 2Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala, Sweden.

    IgG degrading enzyme of Streptococcus pyogenes (IdeS) cleaves human IgG in two steps, first cleaving one of the heavy chains resulting in a single-cleaved IgG…
  • « Previous Page
  • 1
  • …
  • 255
  • 256
  • 257
  • 258
  • 259
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences